Association between admission blood urea nitrogen and in-hospital mortality in patients with acute pulmonary embolism: a retrospective cohort study

Blood urea nitrogen (BUN) is a routinely available biomarker influenced by renal perfusion, volume status, neurohormonal activation, and catabolic state. Evidence relating admission BUN to short-term outcomes in acute pulmonary embolism (PE) may be affected by disease severity and comorbidity. We evaluated the association between admission BUN and in-hospital all-cause mortality in adults with acute PE. Among 798 adults admitted with confirmed acute PE during January 2023–November 2024, 767 had admission BUN measurements. Incomplete variables in the descriptive tables and regression were multiply imputed using R mice (50 datasets, 20 iterations); BUN and mortality were not imputed. Logistic estimates were pooled using Rubin’s rules; Model 3 adjusted for age, sex, diabetes and central PE. Complete-case and ridge-penalized analyses assessed sensitivity. A restricted cubic spline explored functional form. A separate analysis reproduced the original 20% missingness screening rule, retaining 657 patients. The median age was 75.0 years, 50.6% were men, and 21 patients died in hospital (2.74%). Mortality was 1.16%, 2.37% and 4.69% across increasing BUN tertiles. Per 1-mmol/L increase in BUN, pooled Model 3 gave OR 1.090, 95% CI 1.019–1.165; P = 0.012 ( n = 767). The complete-case estimate was similar (OR 1.091, 95% CI 1.020–1.167; P = 0.011; n = 766), whereas the complete-case ridge estimate was attenuated (OR 1.052, 95% CI 0.995–1.113; P = 0.075). The 657-patient sensitivity analysis gave a directionally consistent pooled estimate (OR 1.128, 95% CI 1.045–1.218; P = 0.002). The pooled spline showed an overall association ( P = 0.040) without evidence of non-linearity ( P = 0.261). Higher admission BUN was associated with in-hospital mortality in this single-center PE cohort. Results were directionally consistent in the 657-patient cohort-selection sensitivity analysis. However, the small number of deaths, attenuation in the ridge-penalized sensitivity analysis of the primary cohort, and absence of standardized PE severity variables limit causal and predictive interpretation. BUN should be regarded as a potential complementary marker requiring external validation, not as a standalone or proven incremental prognostic tool.

Authors

Institutions

Publication Details

Journal
BMC Pulmonary Medicine
Published
2026-11-19
DOI
https://doi.org/10.1186/s12890-026-04964-y
Primary Topic
Venous Thromboembolism Diagnosis and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Association between admission blood urea nitrogen and in-hospital mortality in patients with acute pulmonary embolism: a retrospective cohort study

Yanping Yang, Qiangqiang Shi
BMC Pulmonary Medicine
Venous Thromboembolism Diagnosis and Management
article

Association between admission blood urea nitrogen and in-hospital mortality in patients with acute pulmonary embolism: a retrospective cohort study

Yanping Yang, Qiangqiang Shi
article en

Abstract

Blood urea nitrogen (BUN) is a routinely available biomarker influenced by renal perfusion, volume status, neurohormonal activation, and catabolic state. Evidence relating admission BUN to short-term outcomes in acute pulmonary embolism (PE) may be affected by disease severity and comorbidity. We evaluated the association between admission BUN and in-hospital all-cause mortality in adults with acute PE. Among 798 adults admitted with confirmed acute PE during January 2023–November 2024, 767 had admission BUN measurements. Incomplete variables in the descriptive tables and regression were multiply imputed using R mice (50 datasets, 20 iterations); BUN and mortality were not imputed. Logistic estimates were pooled using Rubin’s rules; Model 3 adjusted for age, sex, diabetes and central PE. Complete-case and ridge-penalized analyses assessed sensitivity. A restricted cubic spline explored functional form. A separate analysis reproduced the original 20% missingness screening rule, retaining 657 patients. The median age was 75.0 years, 50.6% were men, and 21 patients died in hospital (2.74%). Mortality was 1.16%, 2.37% and 4.69% across increasing BUN tertiles. Per 1-mmol/L increase in BUN, pooled Model 3 gave OR 1.090, 95% CI 1.019–1.165; P = 0.012 ( n = 767). The complete-case estimate was similar (OR 1.091, 95% CI 1.020–1.167; P = 0.011; n = 766), whereas the complete-case ridge estimate was attenuated (OR 1.052, 95% CI 0.995–1.113; P = 0.075). The 657-patient sensitivity analysis gave a directionally consistent pooled estimate (OR 1.128, 95% CI 1.045–1.218; P = 0.002). The pooled spline showed an overall association ( P = 0.040) without evidence of non-linearity ( P = 0.261). Higher admission BUN was associated with in-hospital mortality in this single-center PE cohort. Results were directionally consistent in the 657-patient cohort-selection sensitivity analysis. However, the small number of deaths, attenuation in the ridge-penalized sensitivity analysis of the primary cohort, and absence of standardized PE severity variables limit causal and predictive interpretation. BUN should be regarded as a potential complementary marker requiring external validation, not as a standalone or proven incremental prognostic tool.

BMC Pulmonary Medicine
Wenzhou Medical University (CN), Dongyang People's Hospital (CN)
Venous Thromboembolism Diagnosis and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon